Chemical Structure : PLX51107
CAS No.: 1627929-55-8
Catalog No.: PC-50010Not For Human Use, Lab Use Only.
PLX51107 (OPN-51107, OPN5) is a novel structurally distinct BET bromodomain inhibitor that inhibits all four BET family proteins BRD2, BRD3, BRD4, and BRDT with low nanomolar potency.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $98 | In stock | |
10 mg | $158 | In stock | |
25 mg | $278 | In stock | |
50 mg | $458 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
PLX51107 (OPN-51107, OPN5) is a novel structurally distinct BET bromodomain inhibitor that inhibits all four BET family proteins BRD2, BRD3, BRD4, and BRDT with low nanomolar potency.
PLX51107 exhibits modest preference for BD1 versus BD2 within each BET protein (Kd=1.6, 2.1, 1.7, and 5 nM for BD1 and 5.9, 6.2, 6.1 and 120 nM for BD2 of BRD2, BRD3, BRD4, and BRDT, respectively).
PLX51107 potently reduces viability and proliferation of the human AML cell lines MV4-11, MOLM-13, OCI-AML3, and Kasumi-1 with IC50 of 0.17, 1.8, 0.2 and 0.2 uM, respectively.
PLX51107 has sufficient potency and oral bioavailability to demonstrate in vivo efficacy in animal models of a variety of tumor types.
M.Wt | 438.487 | |
Formula | C26H22N4O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(S)-4-(6-(3,5-dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid |
1. Ozer HG, et al. Cancer Discov. 2018 Jan 31. pii: CD-17-0902.
2. Nicole R. Grieselhuber, et al. Blood 2016 128:3941.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright